You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: February 6, 2025

Drug Price Trends for NDC 00536-1213


✉ Email this page to a colleague

« Back to Dashboard


Average Pharmacy Cost for 00536-1213

Drug Name NDC Price/Unit ($) Unit Date
MUCUS RLF DM MAX ER 1200-60 MG 00536-1213-88 0.53814 EACH 2025-01-22
MUCUS RLF DM MAX ER 1200-60 MG 00536-1213-88 0.54786 EACH 2024-12-18
MUCUS RLF DM MAX ER 1200-60 MG 00536-1213-88 0.55084 EACH 2024-11-20
MUCUS RLF DM MAX ER 1200-60 MG 00536-1213-88 0.54448 EACH 2024-10-23
MUCUS RLF DM MAX ER 1200-60 MG 00536-1213-88 0.55409 EACH 2024-09-18
MUCUS RLF DM MAX ER 1200-60 MG 00536-1213-88 0.56382 EACH 2024-08-21
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Best Wholesale Price for NDC 00536-1213

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Dates Price Type
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Market Analysis and Price Projections for the Drug NDC: 00536-1213

Understanding the National Drug Code (NDC)

Before diving into the market analysis and price projections for the drug identified by the NDC 00536-1213, it is essential to understand what an NDC is. The National Drug Code (NDC) is a unique 10-digit or 11-digit number that serves as a universal product identifier for human drugs in the United States. It is divided into three segments: the labeler code, the product code, and the package code[4].

Identifying the Drug

To analyze the market and project prices for a specific drug, we need to identify the drug associated with the NDC 00536-1213. However, the provided sources do not specify the drug name for this particular NDC. Typically, databases like DrugPatentWatch or Drugs.com would provide this information.

Market Analysis

General Trends in Drug Pricing

The pharmaceutical market is subject to various trends and factors that influence drug pricing. For instance, the overall drug price inflation rate for 2025 is projected to be 3.81%, according to Vizient's summer Pharmacy Market Outlook for 2024[2].

Impact of Patent Expirations

Patent expirations significantly affect drug prices. For example, in the NSCLC market, the patent expiration of blockbuster drugs like Tarceva and Alimta has led to a decline in their sales and an increase in generic sales. This trend can be expected for other drugs as well, once their patents expire[3].

Role of Immunotherapies and Targeted Therapies

Immunotherapies and targeted therapies are driving growth in various therapeutic areas. In the NSCLC market, immunotherapies like Keytruda, Opdivo, and Tecentriq are projected to achieve blockbuster status by 2025, with significant sales contributions. Targeted therapies, such as Tagrisso and Avastin, also play a crucial role in market growth[3].

Price Projections

Factors Influencing Price Projections

Price projections for a drug are influenced by several factors, including:

  • Market Demand: The demand for the drug, which can be driven by its efficacy, side effect profile, and the prevalence of the condition it treats.
  • Competitive Landscape: The presence of competitors, including generic and branded alternatives.
  • Regulatory Environment: Changes in regulatory policies, such as those related to pricing and reimbursement.
  • Economic Conditions: Overall economic trends and healthcare spending.

Pricing Data Sources

For accurate price projections, one would typically refer to databases that track drug prices over time. For example, DrugPatentWatch provides detailed pricing data for various drugs, including historical prices and future projections[1].

Case Study: NSCLC Market

While the specific drug associated with NDC 00536-1213 is not identified, we can look at the NSCLC market as a case study to understand how market analysis and price projections are conducted.

  • Immunotherapies: By 2025, immunotherapies in the NSCLC market are projected to reach $17.5 billion in sales, with Keytruda, Opdivo, and Tecentriq being major contributors[3].
  • Targeted Therapies: Targeted therapies, such as Tagrisso and Avastin, are expected to contribute significantly to the market growth, with Tagrisso projected to achieve $1.7 billion in sales by 2025[3].

Medicare Part B and Average Sales Price (ASP)

For drugs covered under Medicare Part B, manufacturers must report the Average Sales Price (ASP) data for individual NDCs. This data is crucial for pricing and reimbursement purposes. The ASP corresponds to the amount of drug represented by the NDC and must be reported at the NDC level[5].

Challenges in Price Projections

Data Availability

One of the primary challenges in making accurate price projections is the availability of detailed and up-to-date data. Without specific data on the drug associated with NDC 00536-1213, precise projections are difficult.

Regulatory Changes

Regulatory changes, such as the proposed shift to a 12-digit NDC format, can impact how data is collected and reported, potentially affecting price projections[4].

Key Takeaways

  • Understanding NDC: The NDC is a critical identifier for drugs, helping in market analysis and price tracking.
  • Market Trends: General trends in drug pricing, such as inflation rates and the impact of patent expirations, are essential for market analysis.
  • Immunotherapies and Targeted Therapies: These therapies are driving growth in various therapeutic areas and should be considered in market analysis.
  • Data Sources: Accurate price projections require reliable data sources, such as DrugPatentWatch and Medicare ASP reports.
  • Regulatory Environment: Changes in regulatory policies can significantly impact price projections.

FAQs

  1. What is the National Drug Code (NDC)?

    • The NDC is a unique 10-digit or 11-digit number that serves as a universal product identifier for human drugs in the United States[4].
  2. How do patent expirations affect drug prices?

    • Patent expirations lead to the entry of generic drugs, which typically reduce the overall price of the medication[3].
  3. What role do immunotherapies play in the NSCLC market?

    • Immunotherapies, such as Keytruda, Opdivo, and Tecentriq, are projected to achieve blockbuster status and dominate a significant portion of the NSCLC market by 2025[3].
  4. Why is the Average Sales Price (ASP) important for Medicare Part B drugs?

    • The ASP is crucial for pricing and reimbursement purposes under Medicare Part B, and manufacturers must report this data at the NDC level[5].
  5. How do regulatory changes impact drug price projections?

    • Regulatory changes, such as the proposed shift to a 12-digit NDC format, can affect how data is collected and reported, potentially influencing price projections[4].

Sources

  1. DrugPatentWatch - Latest drug prices and trends for NDC 59630-0551.
  2. DrugPatentWatch - Latest drug prices and trends for NDC 00115-1320.
  3. Drug Development & Delivery - NSCLC MARKET - Global Drug Forecast & Market Analysis to 2025.
  4. Drugs.com - National Drug Codes Explained: What You Need to Know.
  5. HHS.gov - Medicare Part B Drug Average Sales Price Reporting by Manufacturers – Blending National Drug Codes.

More… ↓

⤷  Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.